<<Disclaimer: Verify this information before applying it to your situation.>>
This summary came over my medscape feed (https://www.medscape.com/viewarticle/887758?src=wnl_edit_tpal&uac=285675HZ)-
NEW YORK (Reuters Health) - A point-of-care (POC) test based on IgA/IgG-deamidated gliadin peptide (DGP) accurately predicts persistent villous atrophy in patients with celiac disease who follow a gluten-free diet, researchers report.
It's not perfect, but it's a step towards reducing the need for duodenal biopsy in those of us who need to monitor villous health. Full article here: http://go.nature.com/2yRxHel
Thoughts?
Best regards
Marne
*Support summarization of posts, reply to the SENDER not the CELIAC List*
Archives are at: Http://Listserv.icors.org/SCRIPTS/WA-ICORS.EXE?LIST=CELIAC